Zobrazeno 1 - 10
of 38
pro vyhledávání: '"P.T.G.A. Nooijen"'
Autor:
I.M. Brouwer de Koning, A. Lemson, N.H.M. Renders, M. Bessems, P.T.G.A. Nooijen, W.A. Draaisma, K. Bosscha
Publikováno v:
Clinical Infection in Practice, Vol 15, Iss , Pp 100147- (2022)
Background: Corynebacterium induced granulomatous mastitis is a rare inflammatory condition of the breast, generally occurring in parous reproductive-aged women, that could simulate inflammatory breast cancer. Therefore, it is important to rule out t
Externí odkaz:
https://doaj.org/article/d1c52bbd28fc47dea28b8b1855c4f812
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W.G. Peters, E. C. van den Broek, J.W.W. Coebergh, P.T.G.A. Nooijen, Maryska L.G. Janssen-Heijnen, A.P. Kater, S.A.M. van de Schans, Eduardus F. M. Posthuma, Henrike E. Karim-Kos
Publikováno v:
European journal of cancer (Oxford, England, 48(6), 889-895. Elsevier Limited
European Journal of Cancer, 48(6), 889-895. Elsevier Ltd.
European Journal of Cancer, 48(6), 889-895. Elsevier Ltd.
We present trends in incidence, early treatment and survival of Chronic Lymphocytic Leukaemia (CLL) between 1989 and 2008, based on population-based data from the Netherlands Cancer Registry. Incidence rates were stable at 5.1 per 100,000 person-year
Autor:
A H van der Veen, P.T.G.A. Nooijen, J Breurs, Richard L. Marquet, Ann L.B. Seynhaeve, A. M. M. Eggermont
Publikováno v:
British Journal of Cancer, 79, 433-439
British Journal of Cancer, 79, pp. 433-439
British Journal of Cancer
British Journal of Cancer, 79(3-4), 433-439. Nature Publishing Group
British Journal of Cancer, 79, pp. 433-439
British Journal of Cancer
British Journal of Cancer, 79(3-4), 433-439. Nature Publishing Group
Isolated perfusion of the extremities with high-dose tumour necrosis factor alpha (TNF-alpha) plus melphalan leads to dramatic tumour response in patients with irresectable soft tissue sarcoma or multiple melanoma in transit metastases. We developed
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Stavast, A. M. M. Eggermont, Eric R. Manusama, P.T.G.A. Nooijen, J.H.W. de Wilt, Richard L. Marquet
Publikováno v:
Journal of Surgical Research, 78, 169-175. Academic Press
Isolated limb perfusion (ILP) with TNFalpha in combination with melphalan and IFNgamma has resulted in an immediate and dramatic tumor response in patients. Such an effect was also noted following ILP in a rat sarcoma model. This model enables us to
Autor:
S.H.M. van Uum, E.J. van Lindert, N. van Alfen, A. R. M. M. Hermus, G. F. F. M. Pieters, Pieter Wesseling, P.T.G.A. Nooijen
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1489-91
Journal of Neurology, Neurosurgery, and Psychiatry, 75, 10, pp. 1489-91
Journal of Neurology, Neurosurgery, and Psychiatry, 75, 10, pp. 1489-91
Contains fulltext : 57241.pdf (Publisher’s version ) (Closed access) In 1970 a 20 year old woman presented with a pituitary chromophobe adenoma for which she underwent transfrontal pituitary surgery. In 1978 she had to be reoperated on because of l
Autor:
Ferdinand Lejeune, Dirk J. Ruiter, Danielle Lienard, Lia Schalkwijk, Nathalie Renard, P.T.G.A. Nooijen, Robert M.W. de Waal, Alexander A.M.M. Eggermont, Bin B.B.R. Kroon
Publikováno v:
Journal of Pathology, 176, pp. 279-287
Journal of Pathology, 176, 279-287
Journal of Pathology, 176, 279-287
Twenty-nine stage IIIA/B melanoma patients treated by isolated limb perfusion (ILP) with a high dose of recombinant human tumour necrosis factor alpha (rHuTNF alpha), interferon gamma (IFN gamma), and melphalan were histologically documented with emp
Autor:
J.W.W. Coebergh, Henrike E. Karim-Kos, Maryska L.G. Janssen-Heijnen, Otto Visser, S.A.M. van de Schans, P.T.G.A. Nooijen, Djamila E. Issa, Peter C. Huijgens
Publikováno v:
Annals of Oncology, 23(1), 171-U512. Oxford University Press
van de Schans, S A M, Issa, D E, Visser, O, Nooijen, P, Huijgens, P C, Karim-Kos, H E, Janssen-Heijnen, MLG & Coebergh, J W W 2012, ' Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007 ', Annals of Oncology, vol. 23, no. 1, pp. 171-U512 . https://doi.org/10.1093/annonc/mdr055
Annals of Oncology, 23(1), 171-U512. Elsevier Ltd.
van de Schans, S A M, Issa, D E, Visser, O, Nooijen, P, Huijgens, P C, Karim-Kos, H E, Janssen-Heijnen, MLG & Coebergh, J W W 2012, ' Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007 ', Annals of Oncology, vol. 23, no. 1, pp. 171-U512 . https://doi.org/10.1093/annonc/mdr055
Annals of Oncology, 23(1), 171-U512. Elsevier Ltd.
Background We studied progress in the fight against non-Hodgkin's lymphoma (NHL) in the Netherlands by describing the changes in incidence, treatment, relative survival, and mortality during 1989–2007. Patients and methods We included all adult pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f65f90ede831f169b98bf4dd6ce204
https://research.vumc.nl/en/publications/06ce512e-0e86-4203-84ad-d015409d51a9
https://research.vumc.nl/en/publications/06ce512e-0e86-4203-84ad-d015409d51a9